Hematology TimesCHMP announces 2 opinions on blinatumomabJuly 31, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Hematology TimesCHMP supports expanded approval for epoetin alfa productsJuly 31, 2018AnemiaPharmacyMyelodysplastic SyndromeB Cell Lymphoma
Hematology TimesCHMP backs 2 biosimilar pegfilgrastim productsJuly 31, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology TimesFDA approves drug for IDH1-mutated AMLJuly 23, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesBreakthrough drugs approved with less stringent criteriaJuly 19, 2018PharmacyRelated Issues
Hematology TimesHealth Canada expands approval of obinutuzumabJuly 10, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesEC approves new use, formulation of dasatinibJuly 6, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Hematology TimesCHMP recommends CAR T for ALL, DLBCLJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesCHMP recommends CAR T for DLBCL, PMBCLJuly 2, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesCHMP backs expanded approval of tocilizumabJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology TimesEC grants blinatumomab full approvalJune 21, 2018Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesPU-H71 receives orphan drug designation for myelofibrosisJune 15, 2018CythemiasPharmacy
